{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Supplementary Table1"],"not_rendered":{"defined_names":1},"read":"whole","date_system":"1900"}

{"sheet":"Supplementary Table1","index":0,"n_rows":19,"n_cols":22,"rows_kept":19,"merged":[[0,0,0,21],[1,0,1,21],[3,0,3,21],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,4,5,4],[4,5,5,5],[4,6,4,7],[4,8,5,8],[4,9,5,9],[4,10,5,10],[4,11,5,11],[4,12,5,12],[4,13,5,13],[4,14,5,14],[4,15,4,17],[4,18,5,18],[4,19,5,19],[4,20,5,20],[4,21,5,21],[18,0,18,21]]}
["Supplementary file 1"]
["Anti-NMDAR encephalitis with MOGAD overlap syndrome, isolated epilepsy, and unilateral thalamus changes: a case report and literature review"]
["* Correspondence: Lili Cui: e-mail: cuilili@gdmu.edu.cn; or Yusen Chen: email: chenyusen925@163.com"]
["Table 1: The coexistence of MOG and NMDAR antibodies with seizures has been reported during the course of the disease."]
["Ref",null,"Age/sex",null,"Initial symptoms and seizures",null,"MRI abnormality",null,null,"MOG-ab (CSF/serum)",null,"NMDAR-ab (CSF/serum)",null,"CSF Leukocytosis(+/-)",null,"Therapy",{"$nulls":3},"courses",null,"Ultimate outcomes"]
[{"$nulls":6},"Lesions of seizures and the thalamus involved","M.E",{"$nulls":7},"Immunotherapy","AEDs (+/-)","Anti-viral（+/-）"]
["Patient 1(3)",null,"10/F",null,"Bilateral optic neuritis in the 1st episode; Focal seizures in the 2nd and 4th episodes.",null,"Right parietal cx in the 2nd onset; A new lesion in the right frontal lobe in the 4th onset.","(-)",null,"(-)/(+) at one year later.",null,"(+)/(-) in the 4th onset.",null,"(+)",null,"IVMP, OP, MT, IVIG, and received RX prophylactic therapy.","(+)","(+)",null,"R",null,"Recovery"]
["Patient 2(10)",null,"31/M",null,"Fever, headache, and generalized seizure in the 1st episode.",null,"The right temporal lobe, parietal and occipital cx in the 1st onset.","(-)",null,"(-)/ (+) in the 4th and 5th onset.",null,"(+)/(-) in the 4th and 5th onset.",null,"(+)",null,"IV DSM, OP, MP, IVIG, AZA, MP retrobulbar injection, HMDT, MMF.","(-)","(+)",null,"R",null,"Symptoms relieved"]
["Patient 3(11)",null,"29/M",null,"Seizures, dysarthria, and hemiparesis in the 1st episode.",null,"Frontotemporal in the 1st onset.","(-)",null,"(+)/(+)",null,"(+)/(-)",null,"(-)",null,"St, IVIG.","(-)","(-)",null,"R",null,"Sequelae due to DSE"]
["Patient 4(12)",null,"19/M",null,"Fever, headache, seizure, memory impairment, and unresponsiveness in the 1st onset.",null,"Normal in the  1st onset; The left frontal lobe, basal ganglia, thalamus, and pons are in the 2nd onset.","(-)",null,"(-)/(+) in the 2nd onset.",null,"(+)/(-) in the 2nd  onset.",null,"(+)",null,"DSM, IVIG, IVMP, OP, AZA.","(-)","(-)",null,"R",null,"Recovery"]
["Patient 5(13)",null,"20/F",null,"Seizure, disorientation, neck stiffness, headache, and fever at the time of onset.",null,"Bilateral cingulate gyrus and the medial region of the superior frontal gyrus, in the upper part of the corpus callosum in the 1st onset.","(-)",null,"(+)/(-) at 27 days after admission.",null,"(+)/(-) at 27 days after admission.",null,"(+)",null,"St, IVIG, PE.","(+)","(-)",null,"M",null,"Recovery"]
["Patient 6(14)",null,"12/M",null,"Fever, headache, loss of consciousness, and generalized tonic seizure in the 1st episode.",null,"Left frontotemporal parietal occipital lobes and right temporal-parietal lobes in the 1st onset.","(-)",null,"(-)/(+) in the 2nd onset.",null,"(+) /(+) in the 2nd onset.",null,"(+)",null,"IVIG, IVMP, RX.","(-)","(+)",null,"R",null,"Sequelae due to DSE"]
["Patient 7(15)",null,"38/M",null,"Right facial numbness, diplopia, blurred vision, etc. in the 1st onset; Tonic-clonic seizure in the 3rd onset.",null,"New serpentine lesions involving the bilateral frontal, temporal, parietal, and occipital Cx (Lace sign), and brainstem lesion in the 3rd onset.","(-)",null,"(-)/(+) in the 3rd onset.",null,"(+)/(+) in the 3rd onset.",null,"(+)",null,"IVMP, OP, IVIG, MMF.","(-)","(-)",null,"R",null,"Recovery"]
["Patient 8(16)",null,"3.4/M",null,"Seizure, abnormal behavior, etc.",null,"Normal.","(-)",null,"(+)",null,"(+)",null,"(+)",null,"St, IVIG, RX, and tocilizumab","(-)","(-)",null,"N.a",null,"Recovery"]
["Patient 9(17)",null,"25/M",null,"Fever, headache, agitation, seizures, etc. in the 1st episode.",null,"Normal in the  1st onset.","(-)",null,"(-)/(+) in the 5th episode.",null,"(+)/(-) in the 5th onset.",null,"(+)",null,"IVMP, IVIG, OP, MMF, RX.","(-)","(-)",null,"R",null,"Symptoms relieved"]
["Patient 10(18)",null,"27/M",null,"Headache, aggressive behavior, tonic-clonic seizure, etc.",null,"Middle cerebellar peduncles, midbrain, and some supratentorial lesions.","(-)",null,"(+)/(-)",null,"(+)/(-)",null,"N.a",null,"IVMP, RX.","(-)","(-)",null,"M",null,"Recovery"]
["Patient 11(19)",null,"37/M",null,"Headache, left limb weakness at the time of onset; Tonic–clonic seizure at 7 days after admission.",null,"The lesion in the medial aspect of the bilateral frontal lobe after a seizure.","(+)",null,"(+)",null,"(+)",null,"(+)",null,"OP.","(+)","(-)",null,"M",null,"Recovery"]
["Our case",null,"29/M",null,"Seizure.",null,"The right thalamus.","(+)",null,"(+)/(+)",null,"(+)/(+)",null,"(+)",null,"IVMP, OP.","(+)","(+)",null,"M",null,"Recovery"]
["Ref: reference; M: male; F: female; CSF: cerebrospinal fluid; WBC: white blood cells; MRI: magnetic resonance Imaging; Cx: cortex; FLAIR: fluid-attenuated inversion recovery; M.E: meninges enhancement; ab: antibody; n.a: not applicable; NMDAR: N-methyl-D-aspartate receptor; MOG: Myelin oligodendrocyte glycoprotein; AEDs: antiepileptic drugs; IV: Intravenous; St: steroids; IVMP: Intravenous methylprednisolone; PE: plasma exchange; RX: rituximab; IVIG: intravenous immunoglobulins; OP: oral prednisone; HDMT: High dose methylprednisolone pulse therapy; AZA: azathioprine; MMF: mycophenolate mofetil; DSM: dexamethasone; MP：methylprednisolone; MT: metho-trexate; R:relapse;M: monophasic; DSE: demyelination syndrome episode."]